TABLE 3.

Multivariable Linear Regression Model of Baseline Summary Scores for Sexual Function, Urinary Irritation, Urinary Incontinence, Hormonal Function, and Bowel Function

Summary Score	Coefficient	P	95% CI
Sexual function
Age (continuous)	−1.24	<.001	−1.39 to −1.09
TIBI-CaP 3–5 (vs 0–2)	−5.95	<.001	−8.53 to −3.38
TIBI-CaP 6–8 (vs 0–2)	−14.74	<.001	−18.34 to −11.15
TIBI-CaP 9+ (vs 0–2)	−30.04	<.001	−36.07 to −24.00
Urinary irritation
Age (continuous)	−0.10	.037	−0.17 to −0.01
TIBI−CaP 3–5 (vs 0–2)	−3.63	<.001	−5.08 to −2.20
TIBI-CaP 6–8 (vs 0–2)	−8.88	<.001	−10.90 to −6.86
TIBI-CaP 9+ (vs 0–2)	−16.86	<.001	−20.30 to −13.42
Urinary incontinence
Age (continuous)	−0.09	.056	−0.19 to 0.002
TIBI-CaP 3–5 (vs 0–2)	−0.56	.516	−2.23 to 1.12
TIBI-CaP 6–8 (vs 0–2)	−4.95	<.001	−7.29 to −2.60
TIBI-CaP 9+ (vs 0–2)	−14.68	<.001	−18.63 to −10.73
Hormonal function
Age (continuous)	0.21	<.001	0.14 to 0.28
TIBI-CaP 3–5 (vs 0–2)	−4.19	<.001	−5.40 to −2.99
TIBI-CaP 6–8 (vs 0–2)	−11.22	<.001	−12.91 to −9.53
TIBI-CaP 9+ (vs 0–2)	−23.36	<.001	−26.21 to −20.50
Bowel function
Age (continuous)	−0.01	.678	−0.07 to 0.48
TIBI-CaP 3–5 (vs 0–2)	−1.57	.003	−2.63 to −0.52
TIBI-CaP 6–8 (vs 0–2)	−6.54	<.001	−8.01 to −5.07
TIBI-CaP 9+ (vs 0–2)	−11.38	<.001	−13.88 to −8.89

Abbreviations: CI, confidence interval; TIBI-CaP, Total Illness Burden Index-Prostate Cancer.